Phase I/II study of sequential therapy with irinotecan and S-1 for metastatic colorectal cancer

BACKGROUND: Both irinotecan (CPT-11) and S-1 are active against colorectal cancer; however, as S-1 is a prodrug of 5-fluorouracil (5-FU), 5-FU and its metabolites might inhibit the antitumour effect of CPT-11. Therefore, we designed a sequential combination, in which CPT-11 infusion was given on day...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshioka, T, Kato, S, Gamoh, M, Chiba, N, Suzuki, T, Sakayori, N, Shibata, H, Shimodaira, H, Otsuka, K, Kakudo, Y, Takahashi, S, Ishioka, C
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2009
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2795445/
https://www.ncbi.nlm.nih.gov/pubmed/19920821
http://dx.doi.org/10.1038/sj.bjc.6605432

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2795445/
https://www.ncbi.nlm.nih.gov/pubmed/19920821
http://dx.doi.org/10.1038/sj.bjc.6605432

Ejemplares similares